Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analogues

Cell Death and Differentiation

Volumn 5, Issue 11, 1998, Pages 946-952

  Danielsson, Carina ^a   Fehsel, Karin ^a   Polly, Patsie ^a   Carlberg, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Melanoma cell lines; Vitamin D3; Vitamin D3 analogues

Indexed keywords

CALCITRIOL; COLECALCIFEROL DERIVATIVE; DIHYDROXYCOLECALCIFEROL; MESSENGER RNA; SEOCALCITOL; VITAMIN D RECEPTOR;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; PLEIOTROPY; PRIORITY JOURNAL;

EID: 0031768375     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400437     Document Type: Article

References (35)

1. 3. Proc. Natl Acad. Sci. USA 78: 4990-4994
2. Bouillon R, Okamura WH and Norman AW (1995) Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 16: 200-257
3. Calverley MJ, Grue-Sorensen G, Bretting C and Binderup L (1995) Chemistry and biology of highly active 22-oxy analogs of 20-epi calcitriol with very low binding affinity to the vitamin D receptor. Proceedings of the 9th workshop on vitamin D Ed. Norman, A.W., Bouillon, R., Thomasset, M.: 85-86
4. 3: interplay with retinoid and thyroid hormone signalling. Eur. J Biochem. 231: 517-527
5. 3 receptor in the context of the nuclear receptor superfamily the central role of retinoid X receptor. Endocrine 4: 91-105
6. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF and Hunziker W (1993) Two nuclear signalling pathways for vitamin D. Nature 361: 657-660
7. 3 receptors in human epithelial cancer cell lines. Cancer Res. 42: 856-859
8. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108: 1083-1086
9. Colston KW, Mackay AG, James SY, Binderup L, Chander S and Coombes PC (1992) EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol. 44: 2273-2280
10. 3 analogue is related to promoter selectivity. J Cell. Biochem. 66: 552-562
11. 3. Can. Res. 47: 21-25
12. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines Cancer Res. 55: 2822-2830
13. 3 analogue (KH1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res. 56: 3570-3576
14. 3 in human malignant melanoma cell lines J.Surg.Res. 61: 12-133
15. 3 metabolites. Cancer Res. 43: 4443-4447
16. 3 receptors in established human cancer cell lines in culture. Cancer Res 42: 1116-1119
17. 3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor α. J. Biol. Chem. 272: 8997-9001
18. Herlyn M (1990) Human melanoma: development and progression. Cancer Metastasis Rev 9: 101-112
19. James SY, Mackay AG and Colston KW (1995) Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J. Mol. Endocrinol. 14: 391-394
20. Jones G and Calverley MJ (1993) A dialogue on analogues. Trends Endocrinol. Metabol. 4: 297-303
21. Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K and Schadendorf D (1997) Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Anticancer Res. 17: 4359-4370
22. Lu C and Kerbel RS (1993) Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol 120: 1281-1288
23. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM (1995) The nuclear receptor Superfamily the second decade. Cell 83: 835-839
24. Mason RS, Pryke AM, Ranson M, Thomas HE and Posen S (1988) Human melanoma cells functional modulation by calciotropic hormones. J. Invest. Dermatol. 90: 834-840
25. Mathiasen IS, Colston KW and Binderup L (1993) EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells J Steroid Biochem. Molec. Biol. 46: 365-371
26. Nayeri S, Danielsson C, Kahlen J-P, Schräder M, Mathiasen IS, Binderup L and Carlberg C (1995) The anti-proliferative effect of vitamin D analogues is not related to the AP-1 pathway, but related to promoter selectivity. Oncogene 11: 1853-1858
27. 3 receptors' structure and function in transcription. Annu. Rev Nutr. 11: 189-216
28. Pols HAP, Birkenhäger JC and van Leeuven JPTM (1994) Vitamin D analogues: from molecule to clinical application. Clin. Endocrinol. 40: 285-291
29. Pothier F, Ouellet M, Julien J-P and Guérin SL (1992) An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol. 11: 83-90
30. Reichel H and Norman AW (1989) Systemic effects of vitamin D. Ann. Rev Med. 40: 71-78
31. Schadendorf D, Fichtner M, Makki A, Alijagic S, Küpper M, Mrowietz U and Henz BM (1996a) Metastatic potential of human melanoma cells in nude micecharacterization of phenotype, cytokine secretion and tumour-associated antigens. Br. J. Cancer 74.
32. Schadendorf D, Kern MA, Artuc M, Pahl HL, Rosenbach T, Fichtner I, Nurnberg W, Tüting S, von Stebut E, Worm M, Makki A, Jurgovsky K, Kolde G and Henz BM (1996b) Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol. 135: 1889-1898
33. 3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated transactivation Mol. Cell. Biol. 15: 1154-1161
34. Vieth R (1990) The mechanisms of vitamin D toxicity Bone Mineral. 11: 267-272
35. Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocr Rev. 13: 719-764